You are here

  • Home
  • Archive
  • Volume 101, Issue 12
  • UK AMD/DR EMR REPORT IX: comparative effectiveness of predominantly as needed (PRN) ranibizumab versus continuous aflibercept in UK clinical practice

Article metrics

Article menu
Download PDFPDF
Clinical science
UK AMD/DR EMR REPORT IX: comparative effectiveness of predominantly as needed (PRN) ranibizumab versus continuous aflibercept in UK clinical practice

 

Online download statistics by month:

Online download statistics by month: May 2017 to September 2024

AbstractFullPdf
May 2017624260191
Jun 20173339870
Jul 20172694344
Aug 20171705140
Sep 20173776869
Oct 20173604839
Nov 20175406946
Dec 201740111649
Jan 20184216635
Feb 20182084624
Mar 20182306431
Apr 20181625441
May 20181593220
Jun 20181433315
Jul 20181433518
Aug 20182033118
Sep 20181892920
Oct 20181012715
Nov 20181462310
Dec 201888165
Jan 2019105188
Feb 2019842110
Mar 201986910
Apr 201959107
May 201997199
Jun 2019732714
Jul 201945192
Aug 201932168
Sep 201930123
Oct 201934132
Nov 201942167
Dec 201944134
Jan 202055167
Feb 202067153
Mar 202094198
Apr 2020127256
May 202047236
Jun 202065135
Jul 2020821611
Aug 202073164
Sep 202096186
Oct 202073146
Nov 20206242
Dec 202087133
Jan 20213996
Feb 20211342
Mar 20216355
Apr 20213043
May 20211841
Jun 2021662
Jul 2021222
Aug 2021442
Sep 2021774
Oct 20218940
Nov 20215131
Dec 202110497
Jan 20227384
Feb 20224573
Mar 20224872
Apr 20224021
May 20228873
Jun 20226250
Jul 20225053
Aug 202215464
Sep 202286135
Oct 202269102
Nov 20224721
Dec 20223983
Jan 20234346
Feb 20236975
Mar 20233623
Apr 20235242
May 20234321
Jun 20234520
Jul 20233940
Aug 20232530
Sep 20233232
Oct 20233320
Nov 20236320
Dec 20238641
Jan 20243120
Feb 20244110
Mar 20244374
Apr 20244061
May 20243850
Jun 20244020
Jul 20243841
Aug 202472124
Sep 20245521
Total911718151048